Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-24 Madaus Martin D Director Other acquisition +11 $186.22 $2K 11
2023-03-03 Snodgres Jon Chief Financial Officer Grant or award +8,795 41,765
2023-03-03 Snodgres Jon Chief Financial Officer Shares withheld for taxes −3,674 $188.00 $691K 38,091
2023-03-03 KURIYEL RALF Senior VP, R&D Grant or award +3,591 25,513
2023-03-03 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −1,247 $188.00 $234K 24,266
2023-03-03 Gebski Christine See Remarks Grant or award +375 33,035
2023-03-03 Gebski Christine See Remarks Shares withheld for taxes −126 $188.00 $24K 32,909
2023-03-03 Hunt Anthony Chief Executive Officer Grant or award +18,584 203,551
2023-03-03 Hunt Anthony Chief Executive Officer Shares withheld for taxes −8,244 $188.00 $1.5M 195,307
2023-03-03 Bylund James Chief Operating Officer Grant or award +625 18,112
2023-03-03 Bylund James Chief Operating Officer Shares withheld for taxes −210 $188.00 $39K 17,902
2023-03-02 Snodgres Jon Chief Financial Officer Grant or award +4,848 32,970
2023-03-02 Snodgres Jon Chief Financial Officer Grant or award · Stock Option (Right to Buy) +5,019 5,019
2023-03-02 KURIYEL RALF Senior VP, R&D Grant or award +3,468 21,922
2023-03-02 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +3,591 3,591
2023-03-02 Gebski Christine See Remarks Grant or award +3,467 32,660
2023-03-02 Gebski Christine See Remarks Grant or award · Stock Option (Right to Buy) +3,590 3,590
2023-03-02 Hunt Anthony Chief Executive Officer Grant or award +19,393 184,967
2023-03-02 Hunt Anthony Chief Executive Officer Grant or award · Stock Option (Right to Buy) +20,080 20,080
2023-03-02 Bylund James Chief Operating Officer Grant or award +8,348 17,487

Page 16 of 23 · 455 trades